Form 4: Tyra Biosciences Director Siddarth Subramony Acquires Stock Options

Director Siddarth Subramony acquired stock options in Tyra Biosciences, Inc. on May 29, 2024, according to a Form 4 filing.

Summary

• Siddarth Subramony, a director of Tyra Biosciences, Inc., acquired stock options on May 29, 2024.
• The options grant the right to buy 18,600 shares of common stock at an exercise price of $15.94.
• The options were granted under the Issuer's Non-Employee Director Compensation Program.
• The options vest monthly, with 1/12th of the total shares vesting each month following the grant date.
• Any remaining unvested portion will vest on the date of the next annual meeting if it occurs before the first anniversary of the grant date, subject to continuous service.
• Subramony is part of the 'Boxer Group' and disclaims beneficial ownership of the securities to the extent he does not have a pecuniary interest therein.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The granting of stock options to a director is a common practice and can be seen as a sign of confidence in the company's future, but it's not a major event on its own.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or those holding 10% or more of a company's shares) trade in their company's stock. This filing indicates a grant of stock options to a director, which is a common form of executive compensation.

Comparison to Industry Standards

• Stock option grants are a typical component of compensation packages for directors in publicly traded companies, particularly in the biotechnology sector.
• The vesting schedule described (monthly vesting with potential for accelerated vesting at the annual meeting) is a fairly standard practice to incentivize continued service.

Stakeholder Impact

• The granting of stock options aligns the director's interests with those of the shareholders, as the value of the options increases if the company's stock price increases.

Key Dates